Company / Current Liabilities per Share
ADMA Biologics, Inc. Current Liabilities per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$0.29
FY2025
5-year range
$0.20 / $0.29
FY2021-FY2025
Trend
+19.6%
vs FY2024
Sector context
#179 of 210
Health Care
What the data says
ADMA Biologics, Inc.'s current liabilities per share of $0.29 is lower than 85% of companies in the Health Care sector (FY2025). Current Liabilities per Share has increased for 3 consecutive years, from $0.20 in FY2022 to $0.29 in FY2025.
Based on SEC 10-K filings.
0.29 in FY2025 with a 5-year CAGR of -2.7%.
Increased from $0.22 to $0.29 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +13.6%
- 5-Year CAGR
- -2.7%
- 10-Year CAGR
- -
Sector benchmark
-98.1% below sector average
Key checks
Key Insights
- ADMA Biologics, Inc.'s current liabilities per share has grown for 3 consecutive years.
- In FY2025, current liabilities per share increased 19.6% year-over-year.
- Ranks #179 out of 210 companies in the Health Care sector.
- Peak current liabilities per share was recorded in FY2016.
Company context
Key Data Points
- Altman Z-Score 3.37 (safe zone, above 2.9 threshold)
- Strong profit margin: 46.4%
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.29 | +19.6% |
| FY2024 | $0.25 | +9.4% |
| FY2023 | $0.22 | +12.0% |
| FY2022 | $0.20 | -30.8% |
| FY2021 | $0.29 | -13.9% |
| FY2020 | $0.34 | +11.1% |
| FY2019 | $0.30 | +15.5% |
| FY2018 | $0.26 | -64.2% |
| FY2017 | $0.73 | -30.1% |
| FY2016 | $1.05 | +130.9% |
As of FY2025 · SEC 10-K · Updated Jul 1, 2026